Stanley Hao

Stanley Hao is the Chief Financial Officer of China Sky One Medical, Inc., a position he’s held since November 2008. Mr. Hao was also recently appointed board secretary of CSKI in June 2008. From January 2006 through June 2008, Mr. Hao served as the President’s Assistant and Financial Officer for Sumitomo Group Canadian Branch, an integrated trading company. Prior to this, Mr. Hao served as Marketing Executive and Canadian Market Analyst for MGM Mirage, an entertainment company that owns and operates casino properties. From September 1997 to September 2004, Mr. Hao was Chief Executive Officer and Co-founder of SunnyZone Consulting Co. Ltd., a financial consulting company. Mr. Hao holds bachelor’s degrees in economics and arts from Beijing University Union and an MBA from the University of Phoenix.
Yan-qing LIU, Founder, Chairman and CEO of China Sky One Medical, Inc., is Chief Executive Officer, President and Director of Harbin Tian Di Ren Medical Science and Technology Company (TDR); he also serves as General Manager of CSKI’s Harbin Bio-Engineering subsidiary. Mr. Liu graduated from the Prophylactic Department of Harbin Medicine University, where he obtained his bachelor’s degree. In 2005 he studied at Tsing Hua University and earned an executive master’s of business. Before establishing his own company, he gained eight years of experience as a reporter at Family Health Newspaper, and he has over 10 years of experience in drug marketing, research and development of new drugs, and enterprise management. Mr. Liu has been instrumental in establishing TDR’s sales program and sales network covering the PRC.